Raymond James Financial Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Sep 30, 2025 · FY), Raymond James Financial Inc reported revenue of $15.9B (+6.6% year on year) and net income of $2.1B (+3.2% year on year).
| Line item | Sep 30, 2025 · FY | Sep 30, 2024 · FY | Sep 30, 2023 · FY | Sep 30, 2022 · FY |
|---|---|---|---|---|
| Revenue from contract with customer | $9.6B | $8.5B | $7.3B | $7.7B |
| Principal transactions | $529.0M | $492.0M | $462.0M | $527.0M |
| Total brokerage revenues | $2.3B | $2.1B | $1.9B | $2.1B |
| Interest income | $4.0B | $4.2B | $3.7B | $1.5B |
| Total revenues | $15.9B | $14.9B | $13.0B | $11.3B |
| Interest expense | ($1.8B) | ($2.1B) | ($1.4B) | ($305.0M) |
| Net revenues | $14.1B | $12.8B | $11.6B | $11.0B |
| Compensation, commissions and benefits | $9.1B | $8.2B | $7.3B | $7.3B |
| Communications and information processing | $752.0M | $662.0M | $599.0M | $506.0M |
| Occupancy and equipment | $308.0M | $296.0M | $271.0M | $252.0M |
| Business development | $291.0M | $257.0M | $242.0M | $186.0M |
| Investment sub-advisory fees | $223.0M | $182.0M | $151.0M | $152.0M |
| Professional fees | $163.0M | $150.0M | $145.0M | $131.0M |
| Bank loan provision for credit losses | $37.0M | $45.0M | $132.0M | $100.0M |
| Other | $505.0M | $373.0M | $500.0M | $325.0M |
| Total non-compensation expenses | $2.3B | $2.0B | $2.0B | $1.7B |
| Total non-interest expenses | $11.4B | $10.2B | $9.3B | $9.0B |
| Pre-tax income | $2.7B | $2.6B | $2.3B | $2.0B |
| Provision for income taxes | $579.0M | $575.0M | $541.0M | $513.0M |
| Net income | $2.1B | $2.1B | $1.7B | $1.5B |
| Preferred stock dividends | $5.0M | $5.0M | $6.0M | $4.0M |
| Net income available to common shareholders, basic | $2.1B | $2.1B | $1.7B | $1.5B |
| Net income available to common shareholders, diluted | $2.1B | $2.1B | $1.7B | $1.5B |
| Earnings per common share – basic (in usd per share) | $10.53 | $9.94 | $8.16 | $7.16 |
| Earnings per common share – diluted (in usd per share) | $10.30 | $9.70 | $7.97 | $6.98 |
| Weighted-average common shares outstanding - basic (in shares) | 202.0M | 207.1M | 211.8M | 209.9M |
| Weighted-average common and common equivalents shares outstanding - diluted (in shares) | 206.6M | 212.3M | 216.9M | 215.3M |
| Available-for-sale securities | $94.0M | $457.0M | ($40.0M) | ($897.0M) |
| Currency translations, net of the impact of net investment hedges | $12.0M | $49.0M | $50.0M | ($114.0M) |
| Cash flow hedges | $0 | ($37.0M) | $1.0M | $70.0M |
| Total other comprehensive income, net of tax | $106.0M | $469.0M | $11.0M | ($941.0M) |
| Total comprehensive income | $2.2B | $2.5B | $1.8B | $568.0M |
| Line item | Jun 30, 2026 · Q3 | Mar 31, 2026 · Q2 | Dec 31, 2025 · Q1 | Jun 30, 2025 · Q3 |
|---|---|---|---|---|
| Revenue from contract with customer | $2.7B | $2.7B | $2.6B | $2.3B |
| Principal transactions | $126.0M | $136.0M | $126.0M | $128.0M |
| Total brokerage revenues | $629.0M | $643.0M | $612.0M | $559.0M |
| Interest income | $994.0M | $960.0M | $1.0B | $990.0M |
| Total revenues | $4.4B | $4.3B | $4.2B | $3.8B |
| Interest expense | ($434.0M) | ($403.0M) | ($441.0M) | ($444.0M) |
| Net revenues | $3.9B | $3.9B | $3.7B | $3.4B |
| Compensation, commissions and benefits | $2.6B | $2.5B | $2.5B | $2.2B |
| Communications and information processing | $203.0M | $206.0M | $194.0M | $191.0M |
| Occupancy and equipment | $85.0M | $80.0M | $80.0M | $77.0M |
| Business development | $95.0M | $75.0M | $81.0M | $77.0M |
| Investment sub-advisory fees | $63.0M | $63.0M | $63.0M | $56.0M |
| Professional fees | $63.0M | $36.0M | $37.0M | $42.0M |
| Bank loan provision/(benefit) for credit losses | ($26.0M) | $5.0M | ($3.0M) | $15.0M |
| Other | $116.0M | $118.0M | $105.0M | $175.0M |
| Total non-compensation expenses | $599.0M | $583.0M | $557.0M | $633.0M |
| Total non-interest expenses | $3.2B | $3.1B | $3.0B | $2.8B |
| Total pre-tax income | $750.0M | $735.0M | $728.0M | — |
| Provision for income taxes | $155.0M | $191.0M | $165.0M | $127.0M |
| Net income | $595.0M | $544.0M | $563.0M | $436.0M |
| Preferred stock dividends | $0 | $2.0M | $1.0M | $1.0M |
| Net income available to common shareholders, basic | $595.0M | $542.0M | $562.0M | $435.0M |
| Net income available to common shareholders, diluted | $595.0M | $542.0M | $562.0M | $435.0M |
| Earnings per common share – basic (in usd per share) | $3.06 | $2.76 | $2.85 | $2.16 |
| Earnings per common share – diluted (in usd per share) | $3.01 | $2.72 | $2.79 | $2.12 |
| Weighted-average common shares outstanding – basic (in shares) | 194.0M | 196.1M | 197.1M | 201.2M |
| Weighted-average common and common equivalent shares outstanding – diluted (in shares) | 197.2M | 199.2M | 201.4M | 205.5M |
| Available-for-sale securities | ($10.0M) | ($10.0M) | $43.0M | $53.0M |
| Currency translations, net of the impact of net investment hedges | ($2.0M) | ($10.0M) | $7.0M | $58.0M |
| Cash flow hedges | ($1.0M) | $0 | ($2.0M) | ($3.0M) |
| Total other comprehensive income/(loss), net of tax | ($13.0M) | ($20.0M) | $48.0M | $108.0M |
| Total comprehensive income | $582.0M | $524.0M | $611.0M | $544.0M |
| Line item | Sep 30, 2025 · FY | Sep 30, 2024 · FY | Sep 30, 2023 · FY | Sep 30, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $11.4B | $11.0B | $9.3B | $6.2B |
| Assets segregated for regulatory purposes and restricted cash | $3.4B | $3.4B | $3.2B | $8.5B |
| Collateralized agreements | $698.0M | $749.0M | $418.0M | $704.0M |
| Trading assets ($1,248 and $1,263 pledged as collateral) | $1.5B | $1.5B | $1.2B | $1.3B |
| Available-for-sale securities ($9 and $11 pledged as collateral) | $6.9B | $8.3B | $9.2B | $9.9B |
| Derivative assets | $68.0M | $103.0M | $265.0M | $188.0M |
| Other investments ($8 and $7 pledged as collateral) | $390.0M | $302.0M | $306.0M | $292.0M |
| Brokerage client receivables, net | $2.8B | $2.7B | $2.5B | $2.9B |
| Other receivables, net | $1.8B | $1.8B | $1.6B | $1.6B |
| Loans, net | $53.2B | $47.3B | $44.9B | $43.2B |
| Deferred income taxes, net | $671.0M | $651.0M | $711.0M | $630.0M |
| Goodwill and identifiable intangible assets, net | $1.8B | $1.9B | $1.9B | $1.9B |
| Other assets | $3.5B | $3.4B | $2.8B | $2.5B |
| Total assets | $88.2B | $83.0B | $78.4B | $81.0B |
| Bank deposits | $58.9B | $56.0B | $54.2B | $51.4B |
| Collateralized financings | $1.1B | $938.0M | $337.0M | $466.0M |
| Trading liabilities | $891.0M | $976.0M | $716.0M | $836.0M |
| Derivative liabilities | $190.0M | $224.0M | $490.0M | $530.0M |
| Brokerage client payables | $5.9B | $5.8B | $5.4B | $11.4B |
| Accrued compensation, commissions and benefits | $2.6B | $2.3B | $1.9B | $1.8B |
| Other payables | $2.0B | $1.9B | $1.9B | $1.8B |
| Other borrowings | $700.0M | $1.0B | $1.1B | $1.3B |
| Senior notes payable | $3.5B | $2.0B | $2.0B | $2.0B |
| Total liabilities | $75.7B | $71.3B | $68.2B | $71.5B |
| Preferred stock | $79.0M | $79.0M | $79.0M | $120.0M |
| Common stock; $.01 par value; 650,000,000 shares authorized; 250,084,168 shares issued and 198,139,594 shares outstanding as of September 30, 2025; 249,972,182 shares issued and 203,291,449 shares outstanding as of September 30, 2024 | 3.0M | 2.0M | 2.0M | 2.0M |
| Additional paid-in capital | $3.2B | $3.3B | $3.1B | $3.0B |
| Retained earnings | $13.6B | $11.9B | $10.2B | $8.8B |
| Treasury stock, at cost; 51,944,574 and 46,680,733 common shares as of September 30, 2025 and 2024, respectively | -4.0B | -3.1B | -2.3B | -1.5B |
| Accumulated other comprehensive loss | ($396.0M) | ($502.0M) | ($971.0M) | ($982.0M) |
| Total equity attributable to Raymond James Financial, Inc. | $12.5B | $11.7B | $10.2B | $9.5B |
| Noncontrolling interests | $1.0M | ($6.0M) | ($27.0M) | ($26.0M) |
| Total shareholders’ equity | $12.5B | $11.7B | $10.2B | $9.4B |
| Total liabilities and shareholders’ equity | $88.2B | $83.0B | $78.4B | $81.0B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $10.0B | $11.2B | $9.9B | $9.2B |
| Assets segregated for regulatory purposes and restricted cash | $3.3B | $3.7B | $3.7B | $3.8B |
| Collateralized agreements | $1.2B | $608.0M | $740.0M | $941.0M |
| Trading assets ($1,410 and $1,248 pledged as collateral) | $1.6B | $1.4B | $1.5B | $1.3B |
| Available-for-sale securities ($8 and $9 pledged as collateral) | $6.5B | $6.4B | $6.6B | $7.2B |
| Derivative assets | $32.0M | $71.0M | $70.0M | $73.0M |
| Other investments ($20 and $8 pledged as collateral) | $383.0M | $399.0M | $398.0M | $315.0M |
| Brokerage client receivables, net | $3.3B | $3.3B | $3.0B | $2.9B |
| Other receivables, net | $2.5B | $1.8B | $1.5B | $1.8B |
| Loans, net | $58.3B | $56.7B | $55.2B | $51.3B |
| Deferred income taxes, net | $465.0M | $549.0M | $623.0M | $642.0M |
| Goodwill and identifiable intangible assets, net | $2.6B | $2.0B | $1.8B | $1.9B |
| Other assets | $4.1B | $3.7B | $3.7B | $3.5B |
| Total assets | $94.2B | $91.9B | $88.8B | $84.8B |
| Bank deposits | $63.3B | $62.4B | $60.2B | $57.2B |
| Collateralized financings | $829.0M | $1.1B | $882.0M | $883.0M |
| Trading liabilities | $891.0M | $726.0M | $883.0M | $920.0M |
| Derivative liabilities | $215.0M | $198.0M | $181.0M | $210.0M |
| Brokerage client payables | $6.9B | $6.6B | $6.1B | $6.2B |
| Accrued compensation, commissions and benefits | $2.6B | $2.1B | $1.9B | $2.2B |
| Other payables | $2.3B | $1.9B | $1.8B | $2.0B |
| Other borrowings | $950.0M | $700.0M | $700.0M | $849.0M |
| Senior notes payable | $3.5B | $3.5B | $3.5B | $2.0B |
| Total liabilities | $81.5B | $79.3B | $76.2B | $72.6B |
| Preferred stock | $0 | $0 | $79.0M | $79.0M |
| Common stock; $.01 par value; 650,000,000 shares authorized; 250,084,168 shares issued and 192,124,666 shares outstanding as of June 30, 2026; 250,084,168 shares issued and 198,139,594 shares outstanding as of September 30, 2025 | 3.0M | 3.0M | 3.0M | 3.0M |
| Additional paid-in capital | $3.2B | $3.2B | $3.1B | $3.2B |
| Retained earnings | $15.0B | $14.5B | $14.1B | $13.1B |
| Treasury stock, at cost; 57,959,502 and 51,944,574 common shares as of June 30, 2026 and September 30, 2025, respectively | -5.1B | -4.7B | -4.3B | -3.7B |
| Accumulated other comprehensive loss | ($381.0M) | ($368.0M) | ($348.0M) | ($438.0M) |
| Total equity attributable to Raymond James Financial, Inc. | $12.7B | $12.6B | $12.6B | $12.3B |
| Noncontrolling interests | $84.0M | $43.0M | $4.0M | $2.0M |
| Total shareholders’ equity | $12.8B | $12.6B | $12.6B | $12.3B |
| Total liabilities and shareholders’ equity | $94.2B | $91.9B | $88.8B | $84.8B |
| Line item | Sep 30, 2025 · FY | Sep 30, 2024 · FY | Sep 30, 2023 · FY | Sep 30, 2022 · FY |
|---|---|---|---|---|
| Net income | $2.1B | $2.1B | $1.7B | $1.5B |
| Depreciation and amortization | $195.0M | $179.0M | $165.0M | $145.0M |
| Deferred income taxes, net | ($52.0M) | ($83.0M) | ($88.0M) | ($16.0M) |
| Premium and discount amortization on available-for-sale securities and bank loans and net unrealized gains/losses on other investments | ($19.0M) | ($36.0M) | ($49.0M) | — |
| Provisions for credit losses and legal and regulatory matters | $122.0M | $21.0M | $292.0M | $111.0M |
| Share-based compensation expense | $254.0M | $254.0M | $237.0M | $192.0M |
| Unrealized gains on corporate-owned life insurance policies, net of expenses | ($133.0M) | ($233.0M) | ($96.0M) | $174.0M |
| Other | $39.0M | $22.0M | $10.0M | $49.0M |
| Collateralized agreements, net of collateralized financings | $223.0M | $270.0M | $157.0M | ($37.0M) |
| Loans (provided to) financial advisors, net of repayments | ($328.0M) | ($223.0M) | ($7.0M) | ($120.0M) |
| Brokerage client receivables and other receivables, net | ($106.0M) | ($362.0M) | $257.0M | ($203.0M) |
| Trading instruments, net | ($145.0M) | ($34.0M) | ($33.0M) | $48.0M |
| Derivative instruments, net | $46.0M | ($151.0M) | ($130.0M) | $479.0M |
| Other assets | $119.0M | $9.0M | ($52.0M) | ($126.0M) |
| Brokerage client payables and other payables | $7.0M | $91.0M | ($6.1B) | ($4.2B) |
| Accrued compensation, commissions and benefits | $279.0M | $404.0M | $123.0M | ($76.0M) |
| Purchases and originations of loans held for sale, net of proceeds from sales of securitizations and loans held for sale | ($202.0M) | ($41.0M) | $49.0M | $33.0M |
| Net cash provided by/(used in) operating activities | $2.4B | $2.2B | ($3.5B) | $72.0M |
| Increase in bank loans, net | ($5.7B) | ($2.6B) | ($1.3B) | ($7.2B) |
| Proceeds from sales of loans held for investment | $245.0M | $415.0M | $680.0M | $213.0M |
| Purchases of available-for-sale securities | ($582.0M) | ($503.0M) | ($611.0M) | ($3.1B) |
| Available-for-sale securities maturations, repayments and redemptions | $2.0B | $2.0B | $1.3B | $1.7B |
| Proceeds from sales of available-for-sale securities | $78.0M | $0 | $0 | $52.0M |
| Additions to property and equipment | ($188.0M) | ($205.0M) | ($173.0M) | ($91.0M) |
| Sales/(purchases) of Federal Reserve Bank (“FRB”) and Federal Home Loan Bank (“FHLB”) stock, net | $11.0M | $0 | — | — |
| Renewable energy tax credit equity investments | ($20.0M) | ($42.0M) | — | — |
| Sales/(purchases) of other investments, net | ($73.0M) | $20.0M | ($6.0M) | — |
| Other investing activities, net | ($57.0M) | ($64.0M) | ($69.0M) | ($93.0M) |
| Net cash used in investing activities | ($4.3B) | ($968.0M) | ($274.0M) | ($7.2B) |
| Increase in bank deposits | $2.9B | $1.8B | $2.8B | $6.3B |
| Repurchases of common stock and share-based awards withheld for payment of withholding tax requirements | ($1.3B) | ($984.0M) | ($862.0M) | ($216.0M) |
| Dividends on common and preferred stock | ($416.0M) | ($383.0M) | ($355.0M) | ($277.0M) |
| Exercise of stock options and employee stock purchases | 31.0M | 46.0M | 46.0M | 52.0M |
| Redemption of preferred stock | $0 | $0 | ($40.0M) | — |
| Proceeds from senior notes issuance, net of debt issuance costs paid | $1.5B | — | — | — |
| Redemption of subordinated notes | ($98.0M) | — | — | — |
| Proceeds from FHLB advances | $750.0M | $1.3B | — | $1.0B |
| Repayments of FHLB advances | ($1.0B) | — | — | ($967.0M) |
| Other financing, net | ($6.0M) | ($2.0M) | ($2.0M) | ($7.0M) |
| Net cash provided by financing activities | $2.4B | $438.0M | $1.4B | $5.9B |
| Effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes | ($35.0M) | $175.0M | $239.0M | ($590.0M) |
| Net increase/(decrease) in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash | $439.0M | $1.8B | ($2.1B) | ($1.8B) |
| Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year | $14.3B | $12.5B | $14.7B | $16.4B |
| Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of year | $14.8B | $14.3B | $12.5B | $14.7B |
| Cash and cash equivalents | $11.4B | $11.0B | $9.3B | $6.2B |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · YTD | Dec 31, 2025 · Q1 | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income | $1.7B | $1.1B | $563.0M | $1.5B |
| Depreciation and amortization | $154.0M | $99.0M | $49.0M | $143.0M |
| Deferred income taxes, net | $129.0M | $112.0M | $35.0M | ($4.0M) |
| Premium and discount amortization on available-for-sale securities and bank loans and net unrealized gains/losses on other investments | ($8.0M) | ($3.0M) | $1.0M | ($19.0M) |
| Provisions for credit losses and legal and regulatory matters, net | ($3.0M) | $21.0M | $2.0M | $107.0M |
| Share-based compensation expense | $183.0M | $133.0M | $79.0M | $199.0M |
| Unrealized gains on corporate-owned life insurance policies, net of expenses | ($152.0M) | $10.0M | ($22.0M) | ($68.0M) |
| Other | $34.0M | $27.0M | $16.0M | $23.0M |
| Collateralized agreements, net of collateralized financings | ($750.0M) | $121.0M | ($272.0M) | ($247.0M) |
| Loans provided to financial advisors, net of repayments | ($471.0M) | ($286.0M) | ($156.0M) | ($194.0M) |
| Brokerage client receivables and other receivables, net | ($1.1B) | ($479.0M) | $206.0M | ($170.0M) |
| Trading instruments, net | ($21.0M) | ($62.0M) | $119.0M | $77.0M |
| Derivative instruments, net | $93.0M | $10.0M | ($27.0M) | $31.0M |
| Other assets | $68.0M | ($44.0M) | ($54.0M) | $78.0M |
| Brokerage client payables and other payables | $909.0M | $621.0M | $5.0M | $331.0M |
| Accrued compensation, commissions and benefits | ($86.0M) | ($493.0M) | ($659.0M) | ($109.0M) |
| Proceeds from sales of securitizations and loans held for sale, net of purchases and originations of loans held for sale | $201.0M | $195.0M | $105.0M | ($71.0M) |
| Net cash provided by operating activities | $843.0M | $1.1B | ($10.0M) | $1.6B |
| Increase in bank loans, net | ($5.5B) | ($3.6B) | ($2.1B) | ($4.0B) |
| Proceeds from sales of loans held for investment | $615.0M | $116.0M | $81.0M | $218.0M |
| Purchases of available-for-sale securities | ($947.0M) | ($409.0M) | ($66.0M) | ($480.0M) |
| Available-for-sale securities maturations, repayments and redemptions | $1.3B | $935.0M | $360.0M | $1.5B |
| Proceeds from sales of available-for-sale securities | $40.0M | $0 | $0 | $78.0M |
| Cash paid for acquisitions, net of cash acquired | ($484.0M) | ($92.0M) | — | — |
| Additions to property and equipment | ($153.0M) | ($91.0M) | ($46.0M) | ($144.0M) |
| Sales of Federal Reserve Bank (“FRB”) and Federal Home Loan Bank (“FHLB”) stock | $0 | $0 | — | — |
| Equity method investments, net of distributions received | ($86.0M) | — | — | — |
| Other investing activities, net | ($94.0M) | ($89.0M) | ($57.0M) | ($65.0M) |
| Net cash used in investing activities | ($5.3B) | ($3.2B) | ($1.9B) | ($2.9B) |
| Increase in bank deposits | $4.4B | $3.5B | $1.3B | $1.2B |
| Repurchases of common stock and share-based awards withheld for payment of withholding tax requirements | ($1.3B) | ($918.0M) | ($513.0M) | ($914.0M) |
| Dividends on common and preferred stock | ($326.0M) | ($221.0M) | ($112.0M) | ($314.0M) |
| Employee stock purchases and exercise of stock options | 33.0M | 23.0M | 9.0M | 26.0M |
| Redemption of preferred stock | ($81.0M) | ($81.0M) | — | — |
| Proceeds from FHLB advances | $400.0M | $300.0M | $250.0M | $750.0M |
| Repayments of FHLB advances | ($400.0M) | ($300.0M) | ($250.0M) | ($950.0M) |
| Proceeds from short-term borrowings | $250.0M | — | — | — |
| Other financing, net | ($11.0M) | ($10.0M) | ($10.0M) | ($8.0M) |
| Net cash provided by/(used in) financing activities | $3.0B | $2.3B | $629.0M | ($171.0M) |
| Effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes | ($50.0M) | ($29.0M) | $29.0M | $48.0M |
| Net decrease in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash | ($1.5B) | $177.0M | ($1.2B) | ($1.4B) |
| Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year | $14.8B | $14.8B | $14.8B | $14.3B |
| Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period | $13.3B | $15.0B | $13.6B | $13.0B |
| Cash and cash equivalents | $10.0B | $11.2B | $9.9B | $9.2B |
| Cash and cash equivalents segregated for regulatory purposes and restricted cash | $3.3B | $3.7B | $3.7B | $3.8B |
Raymond James Financial Inc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.